Logo

PD-L1 Biomarkers

News and reporting on PD-L1 biomarkers.

Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
Premium

The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.

BostonGene Closes $150M Series B Funding Round

The firm will use the financing to further the development, clinical expansion, and international availability of its Tumor Portrait tests.

EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access
Premium

The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments.

Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities

The Community Clinical Oncology Research Network will leverage Labcorp's comprehensive genomic profiling test to build out a registry of diverse patient data. 

Astronomy, Biology Come Together for Cancer Biomarker Discovery
Premium

Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.

May 7, 2021

Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study

Apr 15, 2021

NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker Study

Dec 2, 2020

Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement
Premium

Nov 13, 2020

FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Apr 30, 2020

Washington University, BostonGene Expand Kidney Cancer Research Collaboration

Nov 6, 2019

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Aug 5, 2019

IncellDx Inks Chinese Collaboration, Distribution Agreements

Jun 1, 2019

ASCO Studies Show Keytruda Increases Five Year Survival in NSCLC, Provides New Gastric Cancer Option
Premium

May 2, 2019

Arcus Biosciences, Strata Oncology Team Up to Advance Anti-PD-1 Drug

Apr 10, 2019

Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database

Apr 9, 2019

Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies
Premium

Jan 15, 2019

Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ
Premium

Dec 5, 2018

Genentech Data Shows Breast Cancer Patient Subgroups May Benefit from Its Drugs
Premium

Aug 21, 2018

FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer

Jun 15, 2018

PDL1 Amplifications Mark Subset of Solid Tumors, May Point to Checkpoint Blockade Response

Jun 5, 2018

WIN Consortium Applies Transcriptomics to Bolster Patient Matching in Precision Oncology Study
Premium

Apr 17, 2018

At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers
Premium

Sep 22, 2017

FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications

Aug 15, 2017

ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing

Breaking News
The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.